Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Elms Steve
Relationship:   Director
City:   Chester
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   2,319,032    

Indirect Shares

   52,249,428      
Direct Value   $1,102,737    

Indirect Value

   $43,247,927      
Total Shares   54,568,460      
Total Value   $44,350,664      


Zeltiq Aesthetics Inc $0 Pernix Therapeutics Holdings $213 ADMA Biologics Inc $524,385 Durata Therapeutics, Inc. $0 Agile Therapeutics Inc $448,700 Marker Therapeutics Inc $126,734 Zosano Pharma Corp $2,705 Zeltiq Aesthetics Inc $0 Pernix Therapeutics Holdings $213 ADMA Biologics Inc $524,385 Durata Therapeutics, Inc. $0 Agile Therapeutics Inc $448,700 Marker Therapeutics Inc $126,734 Zosano Pharma Corp $2,705
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    5    

     Stock price went up :
    1   
    5    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   5.0   
     Percentage Gain/Loss :
   57.8%
 54.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Map Pharmaceuticals Inc MAPP Director 2010-03-10 0 2010-02-11 0    Premium*  
            Zeltiq Aesthetics Inc ZLTQ 10% Owner 2014-01-23 2,398 2014-01-23 2,597,742    Premium*  
            Pernix Therapeutics Holdings PTX Director 2012-03-22 10,000 2012-03-22 2,000,000    Premium*  
            Melinta Therapeutics, Inc MLNT 10% Owner 0 2012-02-07 3,293,060    Premium*  
            ADMA Biologics Inc ADMA 2024-03-19 76,441 2024-03-19 2,115,671    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 2014-05-20 6,182 2014-03-21 3,030,175    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 2013-07-01 0 2015-04-24 1,837,125    Premium*  
            Asensus Surgical Inc ASXC 10% Owner 0 2014-04-21 8,335,819    Premium*  
            Agile Therapeutics Inc AGRX 10% Owner 2014-05-23 2,171,831 0    Premium*  
            Loxo Oncology, Inc. LOXO Director, 10% Owner 0 2019-02-15 2,038,920    Premium*  
            T2 Biosystems, Inc. TTOO 10% Owner 2014-08-12 0 2014-08-12 2,523,300    Premium*  
            Cidara Therapeutics, Inc. CDTX Director 0 2015-04-20 1,054,610    Premium*  
            Viewray, Inc. VRAY 10% Owner 0 2016-03-30 7,461,923    Premium*  
            Viracta Therapeutics Ord Shs VIRX 10% Owner 2019-07-15 0 2019-07-15 10,100,000    Premium*  
            Marker Therapeutics Inc MRKR Director 2021-06-08 29,680 2021-06-08 3,142,857    Premium*  
            Zosano Pharma Corp ZSAN Director 2021-06-10 22,500 2021-06-10 2,718,226    Premium*  
* Premium Members only  

Records found :    50         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MAPP Map Pharmaceuticals Inc Director   –       •      –    2010-02-11 4 D $0.00 $0 D/D (2,088) 2,088 0 -
MAPP Map Pharmaceuticals Inc Director   –       •      –    2010-02-22 4 A $0.00 $0 D/D 2 2,030 0 -
MAPP Map Pharmaceuticals Inc Director   –       •      –    2010-03-10 4 S $16.15 $33,754 D/D (2,090) 0 0 -
ZLTQ Zeltiq Aesthetics Inc 10% Owner   –       –       •   2011-10-24 4 B $13.00 $10,000,003 I/I 769,231 4,172,742 1.5 -
MLNT Melinta Therapeutics, Inc 10% Owner   –       –       •   2012-02-07 4 B $6.00 $7,281,978 I/I 1,213,663 3,293,060 1.5 -
ADMA ADMA Biologics Inc Director   –       •      –    2012-02-13 4 A $0.00 $0 I/I 2,516,855 2,516,855 0 -
PTX Pernix Therapeutics Holdi... Director   –       •      –    2012-03-22 4 A $0.00 $0 D/D 10,000 10,000 0 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2012-07-24 4 A $0.00 $0 I/I 2,019,713 2,019,713 0 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2012-07-24 4 B $9.00 $9,999,999 I/I 1,111,111 3,130,824 1.5 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 A $0.00 $0 I/I 1,816,475 1,816,475 0 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 B $14.00 $3,333,666 I/I 238,119 2,054,594 1.5 -
ADMA ADMA Biologics Inc 10% Owner   –       –       •   2013-10-22 4 B $8.50 $3,500,003 I/I 411,765 3,620,143 1.5 -
ZLTQ Zeltiq Aesthetics Inc 10% Owner   –       –       •   2013-11-14 4 S $12.22 $7,026,500 I/I (575,000) 3,597,742 0 -
ASXC Asensus Surgical Inc 10% Owner   –       –       •   2013-12-06 4 A $0.00 $0 I/I 12,401,764 36,490,260 0 -
ZLTQ Zeltiq Aesthetics Inc 10% Owner   –       –       •   2014-01-23 4 A $0.00 $0 D/D 8,247 2,398 0 -
ZLTQ Zeltiq Aesthetics Inc 10% Owner   –       –       •   2014-01-23 4 D $0.00 $0 D/D (4,715) 0 0 -
ZLTQ Zeltiq Aesthetics Inc 10% Owner   –       –       •   2014-01-23 4 D $0.00 $0 I/I (994,305) 2,597,742 0 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2014-03-20 4 S $15.74 $1,542,589 I/I (98,000) 3,032,824 0 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2014-03-21 4 S $15.57 $41,255 I/I (2,649) 3,030,175 0 -
ASXC Asensus Surgical Inc 10% Owner   –       –       •   2014-04-21 4 B $4.00 $4,151,068 I/I 1,037,767 8,335,819 1.5 -
DRTX Durata Therapeutics, Inc. 10% Owner   –       –       •   2014-05-20 4 D $0.00 $0 D/D (749,258) 0 0 -
LOXO Loxo Oncology, Inc. Director   –       •       •   2014-08-06 4 A $0.00 $0 I/I 2,850,709 3,039,416 0 -
LOXO Loxo Oncology, Inc. Director   –       •       •   2014-08-06 4 B $13.00 $5,370,001 I/I 413,077 3,452,493 2.25 -
TTOO T2 Biosystems, Inc. 10% Owner   –       –       •   2014-08-12 4 B $11.00 $4,999,995 I/I 454,545 2,523,300 1.5 -
TTOO T2 Biosystems, Inc. 10% Owner   –       –       •   2014-08-12 4 A $0.00 $0 I/I 2,068,755 2,068,755 0 -
  50  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us